pSivida

Follow
Get notifications in MyBN when activity occurs.

pSivida is a leading provider of miniaturised, sustained-release drug delivery products and is continuing the evolution of these systems.

Formerly an ASX-listed company, pSivida's intellectual property portfolio consists of over 150 issued patents in countries including the US, Europe, Japan, China and Australia.

pSivida, a NASDAQ-listed company, is developing products designed to revolutionise treatments, with a primary focus in ophthalmology.

Contact Details

Company Activity

Entrepreneurial trio keen for more
NEWS: Tagged in Entrepreneurial trio keen for more16 Jun 2022

News Articles

STANDING BY BUSINESS. TRUSTED BY BUSINESS.

Subscription Options